Marijuana producer MedMen which just went public this past May, reported first quarter fiscal year 2019 financial results this week that showed an increase of over 1,000% in sales.

“Our first quarter performance underlines the successful execution of our growth strategy and ongoing commitment to provide mainstream cannabis consumers a wide breadth of products for their lifestyle and wellness needs,” said Adam Bierman, MedMen chief executive and co-founder.

He added, “Our four-pillars strategy – built around a quality team, superior assets, strong balance sheet and the ability to efficiently and effectively raise and deploy capital – has set us up to successfully achieve our vision. We are now entering a new phase focused on fully operationalizing our vast footprint.”

The company reported fiscal first-quarter net losses of $12.5 million, or $1.42 a share, compared with $5.3 million in the year-ago period. Revenue climbed to $21.5 million from $1.8 million in the year-ago period. This was an increase of 1,094%.

It was earlier this month that the company’s CFO James Parker quit and the company said it planned to reduce the size of its latest round of financing by roughly 40% to $75 million, from the $120 million it had announced Nov. 9.

The company did not comment on the CFO’s departure and appointed the company’s vice president of accounting, Jim Miller, as interim CFO.

Disclaimer: We have no position in Medmen Enterprises Inc. (OTCMKTS: MMNFF) and have not been compensated for this article.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cincinnati May Eliminate Drug Testing for Marijuana For City Jobs
24 October 2019
Pet Owners Need to Be Aware Of the Dangers of Marijuana
11 July 2018
Lawmakers in California Approve Bill to Allow Medical Marijuana on K-12 Campuses
29 August 2019